Formulation

Watch our special roundtable to learn about pharma industry trends and events post-COVID-19.

From chasing drug lords to advising US presidents, it’s fair to say Robert Pinco has enjoyed a varied career.

Researchers examine how changes in the gut – including those that result from posture – affect drug bioavailability.

Keith Horspool reflects on the efforts that led the FDA to launch its pilot review program for novel excipients

Determining full versus empty capsids remains a key challenge with adeno-associated viral vectors.

Exploring the potential of self-amplifying RNA and circular RNA in the future of drug development.

As new treatment modalities emerge, drug developers are turning to synthetic chemistry – and partners like Veranova.

We interview Chris Moreton to find out more about his career and why formulation is such a fascinating area to pursue.

How can data be stored in candy? And how could it be used to fight counterfeit medicine?

What difference can taste-masking make to the patient experience?